Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine

Clinical trial NCT01113047 · COMPLETED

Trial details

NCT number: NCT01113047
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2010-05-01
Primary completion: 2010-10-01
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.